HSCT Remains the Only Cure for Patients with Transfusion-Dependent Thalassemia until Gene Therapy Strategies Are Proven to Be Safe

The authors review current critical points of hematopoietic stem cell transplantation using alternative donors and assessing recently reported safety issues of gene therapy methods, and conclude that, although a breakthrough, the safety of gene therapy remains to be established.